-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QJxY9CZ2zOP11dCwIe8/E/K78PYxeu98I4/HUCfgtKLEbzBl+l19NVKyZtCvy3Uk JgDxjD/9JvqngjU1talwpA== 0000916641-98-001279.txt : 19981125 0000916641-98-001279.hdr.sgml : 19981125 ACCESSION NUMBER: 0000916641-98-001279 CONFORMED SUBMISSION TYPE: 8-A12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19981124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDCO RESEARCH INC CENTRAL INDEX KEY: 0000723385 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953318451 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12B SEC ACT: SEC FILE NUMBER: 001-09771 FILM NUMBER: 98758384 BUSINESS ADDRESS: STREET 1: 85 T W ALEXANDER DRIVE P O BOX 13886 STREET 2: STE 308 CITY: RESEARCH TRIANGLE PA STATE: NC ZIP: 27709 BUSINESS PHONE: 9195498117 MAIL ADDRESS: STREET 1: 85 T W ALEXANDER DRIVE STREET 2: STE 308 CITY: RESEARCH TRIANGLE PA STATE: NC ZIP: 27709 8-A12B 1 FORM 8-A FORM 8-A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 MEDCO RESEARCH, INC. -------------------- (Exact name of registrant as specified in its charter) Delaware 95-3318451 - -------------------------------------------------------------------------------- (State of incorporation or organization) (I.R.S. Employer Identification No.) 7001 Weston Parkway, Cary, North Carolina 27513 - --------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Securities to be registered pursuant to Section 12(b) of the Act: Name of each exchange Title of each class on which each class is to be so registered to be registered ------------------- ---------------- Common Stock, par value $.001 New York Stock Exchange Securities to be registered pursuant to Section 12(g) of the Act: None ---------------- (Title of Class) Item 1. Description of Registrant's Securities to be Registered Common Stock, $.001 Par Value The capital stock of Medco Research, Inc. (the "Company" or "Registrant") to be registered on the New York Stock Exchange, Inc. is the Registrant's Common Stock with a par value of $.001 per share. Holders of the Common Stock are entitled to one vote per share at all meetings of stockholders. Dividends that may be declared on the Common Stock will be paid in an equal amount to the holder of each share of such Stock. No pre-emptive rights are conferred upon the holders of such Stock and there are no liquidation or conversion rights. Nor are there any redemption or sinking fund provisions, and there is no liability to further calls or to assessments by the Registrant. Item 2. Exhibits 1. All exhibits required by Instruction II to Item 2 will be supplied to the New York Stock Exchange, Inc. SIGNATURE Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized. MEDCO RESEARCH, INC. Date: November 23, 1998 /s/ Glenn Andrews ------------------------------ Name: Glenn Andrews Title: Chief Financial Officer Vice President-Finance & Administration 2 -----END PRIVACY-ENHANCED MESSAGE-----